Digital Legal Office Culture Lead at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Bachelor’s degree in Instructional Design, Organizational Leadership, Organizational Management, Communications, Public Relations, or related degree
5+ years of relevant professional experience
3+ years of experience in Learning & Development, Training & Awareness, Communications, and/or Organizational Change Management (OCM) roles
Qualified applicants must be authorized to work in the United States on a full-time basis (Lilly will not provide support for or sponsor work authorization and/or visas for this role)

Responsibilities

Own the development and execution of enterprise-wide Privacy & AI training and awareness strategy, in alignment with the DLO Governance Framework responsibilities, to influence the culture across the enterprise
Serve as a key resource and advisor for DLO culture initiatives and Organizational Change Management (OCM), shaping the approach to Privacy & AI risk and compliance and influencing senior leaders, privacy personnel, and cross-functional teams
Lead large-scale culture and training projects, managing budgets and resources set by management
Oversee the planning, execution, and measurement of training programs, ensuring they meet organizational needs and compliance requirements
Anticipate changes in Privacy and AI regulations and organizational needs, developing proactive action plans to address emerging risks and opportunities
Anticipate and resolve complex privacy training and culture challenges that impact the Digital Legal Office and related business areas
Own and manage DLO content channels, including intranet sites, newsfeed, internal social media groups, AI chatbots, and SharePoint/Teams sites
Develop and deliver internal training and business communication tactics that support the maturity of Privacy and AI risk and compliance
Responsible for strategic planning and delivery of Data Privacy Week, DLO collaboration days, and full team meetings
Support DLO control owners with communications and OCM
Manage DLO onboarding/offboarding process and training plans
Collaborate with legal, compliance, and technical teams to embed key messages into digital transformation initiatives

Skills

Privacy Awareness

AI Ethics

Data Governance

Training Program Development

Organizational Change Management

Stakeholder Engagement

Compliance

Risk Management

Project Management

Communication

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free